Please assess the completion status of the following clinical trial:

Trial Title: Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* White Males and females who have given written informed consent.~* Ages 18 through 25;also, patients must weigh ≥40 kg and ≤140 kg.~* Good physical health as determined by a complete physical examination, an EKG within normal limits, and laboratory screening tests within acceptable parameters.~* At least an average of one episode of binge or heavy drinking per week in the past month prior to enrollment. For men and women, that is ≥5 and ≥4 drinks/drinking day, respectively.They also need to report at least one day of heavy drinking within the 7 days prior to randomization.~* The pregnancy test for females at intake must be negative. Additionally, women of childbearing potential must be using an acceptable form of contraception.~* Literate in English and able to read, understand, and complete the rating scales and questionnaires accurately, follow instructions, and make use of the behavioral treatments.~* Answer an advertisement in the newspaper/radio/television, and express a wish to stop heavy drinking.~* Willingness to participate in behavioral treatments to stop heavy drinking~Exclusion Criteria:~Please contact site for additional information

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 25 Years
- Healthy Volunteers: f

Study Arms:
- Ondansetron (Type: EXPERIMENTAL): Ondansetron + BASICS Plus
- Placebo (Type: PLACEBO_COMPARATOR): Placebo + BASICS Plus

Based on this trial design, predict the completion outcome and termination type (if applicable).